We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLNY
176
DELISTED
Colony Capital, Inc.
CLNY
| $8.69M | 0.12% |
383,412
+76,109
| +25% | +$1.93M |
|
177
Capital One
COF
$128B
| $8.67M | 0.12% |
98,513
+83,935
| +576% | +$7.05M |
|
178
Madison Square Garden
MSGS
$9.48B
| $8.59M | 0.12% |
144,283
+72,781
| +102% | +$4.36M |
|
|
HCBK
179
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $8.47M | 0.12% |
857,231
-791,656
| -48% | -$7.64M |
|
180
US Bancorp
USB
$98.2B
| $8.43M | 0.12% |
194,237
+91,237
| +89% | +$3.99M |
|
181
Chord Energy
CHRD
$7.9B
| $8.42M | 0.12% |
531,208
+263,292
| +98% | +$4.43M |
|
182
Ulta Beauty
ULTA
$22B
| $8.42M | 0.12% |
54,505
+21,907
| +67% | +$3.37M |
|
183
SPX Corp
SPXC
$11B
| $8.39M | 0.12% |
+460,100
| New | +$8.97M |
|
|
HSP
184
DELISTED
HOSPIRA INC
HSP
| $8.37M | 0.12% |
94,387
-86,704
| -48% | -$7.64M |
|
|
CSOD
185
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $8.36M | 0.12% |
240,102
+178,802
| +292% | +$5.56M |
|
|
CLR
186
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $8.24M | 0.12% |
194,309
+173,690
| +842% | +$8.26M |
|
187
Sabre
SABR
$731M
| $8.22M | 0.12% |
+345,235
| New | +$8.7M |
|
|
PNK
188
DELISTED
Pinnacle Entertainment Inc.
PNK
| $8.09M | 0.11% |
216,887
-24,139
| -10% | -$888K |
|
189
Carlisle Companies
CSL
$14.3B
| $8.08M | 0.11% |
80,701
-4,299
| -5% | -$422K |
|
190
Union Pacific
UNP
$174B
| $8.04M | 0.11% |
84,291
-337,105
| -80% | -$35.1M |
|
191
James River Group Holdings
JRVR
$208M
| $8.02M | 0.11% |
310,103
+7,483
| +2% | +$179K |
|
192
Intercontinental Exchange
ICE
$85.6B
| $7.96M | 0.11% |
177,895
+125,395
| +239% | +$5.82M |
|
|
FOMX
193
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $7.93M | 0.11% |
+774,000
| New | +$8.55M |
|
194
RenaissanceRe
RNR
$13.3B
| $7.87M | 0.11% |
77,481
-5,722
| -7% | -$590K |
|
|
CYBR
195
DELISTED
CyberArk
CYBR
| $7.85M | 0.11% |
125,000
+74,500
| +148% | +$4.77M |
|
196
Cheesecake Factory
CAKE
$5.04B
| $7.71M | 0.11% |
+141,463
| New | +$7.31M |
|
197
CME Group
CME
$96.3B
| $7.69M | 0.11% |
82,603
+46,711
| +130% | +$4.36M |
|
198
Honeywell
HON
$77B
| $7.63M | 0.11% |
83,286
-44,658
| -35% | -$4.16M |
|
199
Pfizer
PFE
$143B
| $7.61M | 0.11% |
239,318
-168,026
| -41% | -$5.48M |
|
200
Herc Holdings
HRI
$5.02B
| $7.61M | 0.11% |
140,036
+136,628
| +4,009% | +$8.45M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.